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Background: Noncommunicable diseases are an increasing health concern worldwide, but particularly in low- and
middle-income countries. This study quantified and compared education- and wealth-based inequalities in the
prevalence of five noncommunicable diseases (angina, arthritis, asthma, depression and diabetes) and comorbidity
in low- and middle-income country groups.
Methods: Using 2002–04 World Health Survey data from 41 low- and middle-income countries, the prevalence
estimates of angina, arthritis, asthma, depression, diabetes and comorbidity in adults aged 18 years or above are
presented for wealth quintiles and five education levels, by sex and country income group. Symptom-based
classification was used to determine angina, arthritis, asthma and depression rates, and diabetes diagnoses were
self-reported. Socioeconomic inequalities according to wealth and education were measured absolutely, using the
slope index of inequality, and relatively, using the relative index of inequality.
Results: Wealth and education inequalities were more pronounced in the low-income country group than the
middle-income country group. Both wealth and education were inversely associated with angina, arthritis, asthma,
depression and comorbidity prevalence, with strongest inequalities reported for angina, asthma and comorbidity.
Diabetes prevalence was positively associated with wealth and, to a lesser extent, education. Adjustments for
confounding variables tended to decrease the magnitude of the inequality.
Conclusions: Noncommunicable diseases are not necessarily diseases of the wealthy, and showed unequal
distribution across socioeconomic groups in low- and middle-income country groups. Disaggregated research is
warranted to assess the impact of individual noncommunicable diseases according to socioeconomic indicators.Background
The attenuation of the noncommunicable disease (NCD)
burden has been cited as one of the greatest develop-
ment challenges of the 21st century [1,2]. In 2008, 80%
of the world’s 36 million NCD-related deaths occurred
in low- and middle-income countries (LMICs), which
are home to most of the world’s population [3]. Globally,
cardiovascular disease and diabetes are responsible for* Correspondence: hosseinpoora@who.int
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distribution, and reproduction in any medium170 million disability adjusted life years (11.3% of global
burden), while cancers account for 78 million disability
adjusted life years (5.1% of global burden), and respira-
tory diseases, 60 million disability adjusted life years (3.9%
of global burden) [3]. Non-fatal NCDs, including depres-
sion [4] and arthritis [5] also contribute significantly to
the global NCD burden. Without immediate and effect-
ive action, global NCD-related mortality is expected to
reach 44 million in 2020, with a growing impact in low-
resource settings [3].
NCDs are unequally distributed within populations,
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at all stages of development found a trend for increased
angina in poorer populations, although associations with
individual- or societal-level socioeconomic markers were
not analyzed [10]. A literature review reported elevated
angina-related mortality and morbidity in less-affluent
neighbourhoods, based on literature from several world
regions [11]. Although few multinational studies of LMICs
have examined the role of socioeconomic inequality in
arthritis prevalence, preliminary research from the Uni-
ted States supported an association of low individual
socioeconomic status with greater likelihood of arthritis
in less-developed settings, and a potential role for com-
munity social determinants [12]. A lower level of formal
education has been linked to higher arthritis prevalence
[13-16], and worse arthritis outcomes [17] in high-income
country settings. Studies that have analyzed associations
between rates of asthma symptoms and country-level
economic status have reported mixed findings [18-21],
although greater asthma severity has been documented
in populations of low socioeconomic status [20-22]. In-
ternational depression studies universally report greater
risk among women and populations of low economic
standing or low levels of education [23,24], while dia-
betes was associated with low socioeconomic status in
two high-income countries [25,26] and lower levels of
education in middle- and high-income countries [8,27,28].
Previous studies from Southeast Asia reported associations
between low education level and increased probability of
having a chronic disease [29] and elevated number of
chronic conditions [30].
In 2011, the international community convened at the
United Nations High Level Summit to discuss approaches
to address the rising trend of NCDs and their risk factors.
In the absence of a concerted commitment amongst stake-
holders, the international response thus far to alleviate this
crisis has been deemed inadequate [31,32]. The amount of
research dedicated to LMICs does not match the distribu-
tion of disease burden [33,34], and previous studies pro-
vide only a highly fragmented overview of the situation.
Furthermore, prevention and treatment initiatives in low-
resource settings are hindered by a lack of attention to
social and economic situations [35].
The 2002–04 World Health Survey (WHS) gathered data
about the symptoms of four major NCDs: angina, arthritis,
asthma and depression as well as the self-reported diagno-
sis of diabetes. The objective of this study was to quantify
and compare the socioeconomic inequalities in prevalence
estimates of these five NCDs and comorbidity in LMICs.
Methods
Study population
Data were obtained from the 2002–04 WHS, conducted
by the World Health Organization [36]. The WHS is asource of comparable population health data of adults
aged 18 years and older in 70 countries from all regions
of the world [37]. Survey samples were probabilistically
selected, with all individuals having a known, non-zero
chance of selection. WHS country surveys were nation-
ally representative except in China, Comoros, Congo,
Côte d'Ivoire, India, and the Russian Federation, where
the WHS was carried out in geographically limited
regions. To adjust for non-response and population dis-
tribution (as represented by the United Nations Statis-
tical Division [38]), post-stratification corrections were
made to sampling weights [4]. Informed consent was
obtained in all surveys, using a procedure approved by
institutional review boards [39]. The full list of local
review boards from each study country is available in
Additional file 1.
Data
This study focused on LMICs, classified according to the
World Bank’s development categories in 2003 [40], con-
sistent with the timing of the majority of the WHS sur-
veys. The 2002–04 WHS included 50 LMICs. Initially
we assessed 48 LMICs that had available NCD preva-
lence data, and relevant socioeconomic and demograph-
ic data. (Guatemala did not have data on survey sampling
weight, and Turkey had insufficient data to create the
household wealth index, one of the principal variables of
the study.) Seven countries were excluded from analysis
because item non-response for any set of the questions
pertaining to NCDs was over 20%. The final sample
comprised 170,298 respondents (77,517 men and 92,781
women) from 41 LMICs. Household level response rates
were over 70% in all study countries except Czech Re-
public. Individual level response rates were above 82%.
See Additional file 2 for study country sample sizes, by
sex, and Additional file 3, for NCD item non-response
rates, by sex.
Variables
We analyzed data for angina, arthritis, asthma, depres-
sion, and diabetes. These represent five of the six chronic
conditions included in section 6000 of the WHS indi-
vidual questionnaire, and prominent NCDs worldwide.
(Psychosis/schizophrenia was not included as a study
variable because its prevalence was too low to allow for
meaningful disaggregated analysis by SES indicators,
controlling for potential confounders.) Symptom-based
classification was used to determine angina, arthritis,
asthma and depression rates, and diabetes diagnoses were
self-reported. The diagnostic criteria to estimate the
prevalence of each disease has been previously described
[4]. Briefly, angina was diagnosed based on an algorithm
derived from the Rose questionnaire [41]. Arthritis and
asthma diagnoses were based on responses to validated
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sis was based on International Classification of Disease
tenth revision: Diagnosis Criteria for Research for De-
pressive Episodes [45], and was derived from an algo-
rithm that took into account depression symptoms [4,46].
For each diagnosis all potential answer combinations were
considered, and the best result based on Receiver Oper-
ator Characteristic analysis within each country was ap-
plied as diagnosis criteria [47]. Diagnoses of these diseases
were based on questions about the respondent’s condi-
tion in the 12 months preceding the interview date. For
diabetes, diagnosis was based on a self-reported previous
diagnosis. Comorbidity was defined as reporting of two
or more NCDs by one individual. Because diabetes diag-
nosis was based solely on self-reported diagnosis (whereas
symptom questions and the algorithm approach were
used to diagnose the other NCDs), an additional comor-
bidity measure excluding diabetes was constructed.
Socioeconomic status was derived from household
wealth status and individual highest-attained level of
education. To measure household wealth, a dichotomous
hierarchical ordered probit model was used to develop
an index of the long-running economic status of house-
holds based on owning selected assets and/or using cer-
tain services [48-50]. The index was then divided into
five quintiles within each country, with quintile one
representing the poorest wealth quintile and quintile
five, the richest. Education was ranked according to five
categories: no formal schooling, less than primary school,
primary school completed, secondary/high school com-
pleted, and college completed or above.
Confounders included sex, age (expressed categorically
as 18–29, 30–39, 40–49, 50–59, 60–69 and 70 or more
years), marital status (married/cohabiting, divorced/separated/
widowed, or never married), area of residence (rural or
urban), and country of residence.
Methods of analysis
Prevalence rates for each NCD and comorbidity were
calculated for men and women in LIC and MIC groups,
according to wealth quintiles and education level. Both
age-standardized [51] and crude prevalence estimates
were calculated.
Socioeconomic inequality in each NCD and comorbid-
ity prevalence was measured using the slope index of in-
equality (SII) and the relative index of inequality (RII),
measures that take into account the distribution of the
population across wealth quintiles or education levels
[52]. Poisson regression model with a robust variance
was used to assess the association between each NCD
prevalence and socioeconomic status and to generate
prevalence difference and prevalence ratio estimates, and
95% confidence intervals (95%CI) [53]. To calculate SII
and RII, individuals were cumulatively ranked (rangingfrom zero to one) according to descending socioeco-
nomic status (i.e. highest wealth or education level to
lowest). The exposure variable can thus be interpreted
as a continuous measure, with a value of zero equivalent
to the top of the socioeconomic distribution and a value
of one equivalent to the bottom. Therefore, SII is the
prevalence rate difference--and RII, the prevalence rate
ratio-- between those at top rank (representing the low-
est level of wealth or education) and those at rank zero
(representing the highest level of wealth or education).
A SII value greater than zero and a RII value greater
than one indicated an inverse gradient, where NCD
prevalence was greater among populations of lower
socioeconomic status. We referred to this situation as
"regular" inequality, and conversely, "reverse" inequality
if prevalence was higher among those with higher socio-
economic position [54]. Data were adjusted for country
of residence and age (Model 1), as well as other con-
founding factors: marital status, urban/rural area and edu-
cation or wealth (Model 2).
StataW 11 was used for all analyses. We imputed miss-
ing values five times using Multiple Imputation by Inte-
grated Chained Equations Technique [55]. All analyses
were weighted, accounting for individual survey sample
designs. The non-independence of observations within
the surveys clusters were also incorporated in the
analysis.
Results
Table 1 shows overall age-standardized prevalence of
NCDs and comorbidity in men and women living in
study LMICs. Overall, angina showed the highest preva-
lence rate. Overall age-standardized prevalence tended
to be elevated in women. Except for depression, age-
standardized prevalence rates were higher in MICs. Crude
prevalence rates of NCDs and comorbidity are shown in
Additional file 4.
Wealth-related inequality
Table 2 summarizes age-standardized prevalence rates
of NCDs and comorbidity by household wealth quin-
tile and absolute inequalities (SII), among men and
women living in study LMICs. Relative inequalities
are illustrated in Figure 1, and RII values are provided
in Additional file 5. Additional file 6 summarizes
crude prevalence of NCDs by wealth among each sex-
income group.
We generally found regular inequality in prevalence
values of angina, arthritis, asthma and depression in
both absolute and relative terms, after controlling for
respondents' age and country of residence (Model 1). Of
all NCDs, angina consistently demonstrated the highest
absolute inequality. Notably, the absolute difference of
angina prevalence between poorest and richest women
Table 1 Age-standardized prevalence (%) of noncommunicable diseases among adults of 41 low- and middle-income
countries, World Health Survey 2002-04
Men Women
Middle-income group Low-income group Middle-income group Low-income group
Estimate 95%CI Estimate 95%CI Estimate 95%CI Estimate 95%CI
Angina 9.8 9.2 10.3 9.1 8.6 9.5 15.1 14.4 15.7 14.1 13.6 14.6
Arthritis 6.6 6.2 7.1 4.4 4.1 4.7 10.0 9.5 10.4 6.1 5.7 6.4
Asthma 6.4 6.0 6.8 5.5 5.1 5.9 6.8 6.4 7.2 6.4 6.0 6.8
Depression 3.9 3.6 4.2 4.9 4.5 5.2 7.0 6.5 7.4 7.8 7.4 8.2
Diabetes 3.7 3.3 4.0 1.4 1.2 1.6 5.0 4.7 5.3 1.5 1.3 1.7
Co-morbidity 6.3 5.9 6.7 4.6 4.3 4.9 10.1 9.6 10.6 7.1 6.7 7.4
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ference: 10.6%, 95%CI 7.2%-13.9%). Arthritis demon-
strated the weakest inequality, and was non-significant
after controlling for other study confounders (Model 2).
Diabetes prevalence was positively associated with in-
creasing wealth quintile. This reverse inequality was
more pronounced in the LIC group, and lost significance
in MICs when data were adjusted for confounders
(Model 2). For example, diabetes prevalence in the poor-
est women living in the study LIC group was one fourth
of the richest in Model 2 (prevalence ratio: 0.24, 95%CI
0.14-0.44).
Comorbidity prevalence showed an inverse association
with wealth quintile in all four sex-income groups; i.e.
regular inequality. In both country income groups comor-
bidity was around 1.5 times more prevalent in the poor-
est women than in the richest in Model 1 (prevalence
ratio: women of study LICs: 1.46, 95%CI 1.19-1.80;
women of study MICs: 1.51, 95%CI 1.14-1.98). Comor-
bidity was 2.5 times more prevalent in the poorest men
of study LICs than in the richest (prevalence ratio: 2.50,
95%CI 1.89-3.30). Wealth-related inequalities in comor-
bidity remained statistically significant in Model 2 in all
sex-income groups except for women living in the LIC
group. Excluding diabetes from the comorbidity measure
strengthened regular inequality, which was robust to ad-
justment for confounding.
Education-related inequality
Table 3 summarizes age-standardized prevalence rates of
NCDs and comorbidity by education and absolute in-
equalities (SII), among men and women living in study
LMICs. Relative inequalities are illustrated in Figure 2,
and RII values are provided in Additional file 7. Additional
file 8 summarizes crude prevalence of NCDs by education
among each sex-income group.
Controlling for age and country of residence, regular
inequalities were reported for the prevalence of angina
and asthma in most study populations. Education-related
inequality was weak or non-significant for arthritisprevalence (except among men of LICs), and also for de-
pression prevalence (except among women of LICs). De-
pression was twice as prevalent among LIC women with
no formal education as women with college/university
education (prevalence ratio: 2.19, 95%CI 1.68-2.87). The
strongest education-related regular inequality was found
among LIC populations for angina. The absolute differ-
ence of angina prevalence between adults with no formal
education and those with college/university education
was near 8% points (prevalence difference: men: 7.6%,
95%CI 5.2%-10.0%; women: 7.8%, 95%CI 4.6%-11.0%). In
MICs, all education-related inverse associations were
non-significant after adjusting for other confounding
factors (Model 2). Diabetes prevalence was associated
with increasing education level (reverse inequality),
demonstrating a significant relationship in LICs, after
adjusting for all confounding factors (prevalence ratio:
men: 0.36, 95%CI 0.20-0.64; women: 0.44, 95% CI 0.22-
0.88).
Comorbidity showed regular inequality, with an in-
verse association between comorbidity prevalence and
education level in all sex-income groups. The absolute
difference in comorbidity prevalence among adults living
in the LIC group was about 5% points across educational
levels in Model 1. Education-related inequality was ro-
bust to adjustment for confounding in the LIC group,
but not the MIC group.
Discussion
Within LICs and MICs, wealth- and education-related
inequalities of variable magnitudes and direction were
quantified for the five NCDs. In most populations, regu-
lar inequalities in terms of wealth and education were
reported for angina, arthritis, asthma and depression,
with the strongest associations for angina, asthma and
comorbidity. For all NCDs, additional adjustments for
confounding factors in Model 2 (marital status, urban/
rural area and wealth/education) tended to decrease the
magnitude of inequality, and may thus help to explain
disparities in NCD prevalence.
Table 2 Noncommunicable disease prevalence (%) by wealth quintile, and wealth-related inequality among adults of 41 low- and middle-income countries,
World Health Survey 2002-04
Angina Arthritis Asthma Depression Diabetes Co-morbidity
Estimate 95% CI Estimate 95% CI Estimate 95% CI Estimate 95% CI Estimate 95% CI Estimate 95% CI
Men Middle-income
group
Wealth quintile 1 13.0 11.9 14.1 6.9 6.1 7.7 9.5 8.4 10.6 5.5 4.7 6.2 2.7 2.2 3.2 8.3 7.4 9.1
Wealth quintile 2 10.5 9.2 11.8 6.8 6.0 7.6 7.7 6.7 8.6 4.0 3.2 4.8 3.0 2.4 3.6 6.6 5.8 7.4
Wealth quintile 3 9.8 8.8 10.8 6.5 5.8 7.2 6.6 5.8 7.4 3.9 3.3 4.6 4.1 3.5 4.7 6.3 5.5 7.0
Wealth quintile 4 8.9 8.0 9.8 7.0 6.2 7.8 5.7 5.0 6.4 4.4 3.7 5.2 3.7 3.2 4.2 6.1 5.3 6.8
Wealth quintile 5 6.9 6.0 7.8 5.1 4.3 5.8 4.1 3.5 4.7 2.3 1.8 2.8 4.3 3.8 4.9 4.1 3.4 4.8
Slope index
of inequality
Model 1* 7.3 5.0 9.6 2.4 0.3 4.5 5.4 3.4 7.5 2.5 1.1 3.8 -1.7 -2.8 -0.5 4.6 2.5 6.6
Model 2** 6.4 3.7 9.1 1.5 -1.0 4.0 3.2 1.0 5.4 2.9 1.0 4.8 -0.8 -2.2 0.6 3.5 1.0 6.0
Low-income
group
Wealth quintile 1 10.8 9.9 11.6 4.5 3.9 5.1 6.7 5.9 7.5 5.7 5.0 6.4 0.7 0.4 1.0 5.7 5.1 6.4
Wealth quintile 2 10.9 10.0 11.8 5.0 4.4 5.6 5.7 5.0 6.4 4.8 4.2 5.5 1.0 0.7 1.3 5.1 4.4 5.7
Wealth quintile 3 9.3 8.4 10.2 4.2 3.7 4.7 5.9 5.2 6.7 4.8 4.1 5.4 1.2 0.9 1.4 4.9 4.2 5.5
Wealth quintile 4 8.2 7.4 9.0 4.7 4.0 5.4 5.4 4.7 6.0 4.7 4.0 5.5 1.4 1.1 1.7 4.4 3.7 5.1
Wealth quintile 5 6.6 5.7 7.4 3.7 3.2 4.3 4.4 3.8 5.0 4.1 3.5 4.7 2.5 2.1 2.9 3.3 2.7 3.9
Slope index
of inequality
Model 1* 7.8 5.9 9.8 2.2 0.8 3.7 4.1 2.7 5.4 2.5 0.8 4.2 -3.4 -4.5 -2.2 5.0 3.5 6.5
Model 2** 5.0 2.8 7.3 0.6 -1.0 2.3 2.5 0.7 4.4 2.0 0.2 3.9 -1.4 -2.7 -0.2 3.5 1.6 5.4
Women Middle-income
group
Wealth quintile 1 18.6 17.4 19.9 9.6 8.7 10.4 9.2 8.4 10.1 9.1 8.2 10.0 4.2 3.6 4.9 12.2 11.3 13.1
Wealth quintile 2 16.9 15.7 18.1 10.5 9.6 11.4 7.8 6.9 8.6 7.3 6.6 8.1 4.9 4.3 5.5 11.4 10.4 12.4
Wealth quintile 3 15.6 14.4 16.8 10.1 9.3 11.0 7.1 6.3 7.8 7.0 6.1 7.8 4.6 4.1 5.1 10.4 9.5 11.3
Wealth quintile 4 13.4 12.3 14.5 10.3 9.4 11.1 5.4 4.8 5.9 7.5 6.7 8.3 5.2 4.5 5.8 9.5 8.7 10.4
Wealth quintile 5 11.9 10.8 12.9 9.8 8.9 10.7 5.6 5.0 6.2 5.1 4.4 5.8 5.6 4.9 6.3 8.3 7.5 9.2
Slope index
of inequality
Model 1* 10.6 7.2 13.9 1.0 -1.5 3.5 4.9 1.7 8.2 3.7 1.9 5.5 -2.2 -4.9 0.5 4.8 1.7 7.8
Model 2** 10.4 6.7 14.2 1.2 -1.8 4.3 4.4 0.9 8.0 3.6 1.4 5.8 -2.5 -5.7 0.7 4.3 0.8 7.9
Low-income
group
Wealth quintile 1 15.4 14.4 16.3 6.3 5.6 7.0 6.4 5.7 7.1 8.6 7.7 9.4 0.6 0.4 0.9 7.3 6.6 8.0
Wealth quintile 2 15.7 14.7 16.8 6.6 5.9 7.2 7.4 6.6 8.2 8.5 7.7 9.3 1.0 0.7 1.2 7.9 7.2 8.7
Wealth quintile 3 14.0 12.9 15.2 6.8 6.0 7.5 6.5 5.7 7.3 8.2 7.4 9.1 1.1 0.8 1.4 7.4 6.6 8.2
Wealth quintile 4 13.2 12.1 14.3 5.8 5.1 6.4 5.8 5.1 6.5 7.6 6.8 8.4 1.7 1.3 2.0 6.4 5.7 7.1
Wealth quintile 5 11.9 10.6 13.2 5.5 4.7 6.3 5.9 5.2 6.6 5.8 5.0 6.6 3.2 2.7 3.7 6.3 5.5 7.2
Slope index
of inequality
Model 1* 7.0 4.3 9.7 2.0 0.3 3.6 1.1 -0.4 2.6 4.2 2.3 6.2 -4.0 -5.3 -2.8 3.1 1.4 4.8
Model 2** 4.9 1.1 8.7 1.1 -1.1 3.2 0.5 -1.3 2.2 1.8 -0.7 4.3 -2.7 -3.9 -1.6 1.2 -0.9 3.3
* Model 1 is adjusted for country of residence and age.




















Figure 1 Wealth-related relative inequality in non-communicable diseases among adults of 41 low- and middle-income countries.
The relative index of inequality shows wealth-related inequality in prevalence of angina, arthritis, asthma, depression, diabetes and comorbidity,
among men and women aged 18 or higher, living in 41 low- and middle-income countries that participated in the 2002–04 World Health Survey.
Individuals were cumulatively ranked by descending wealth, and prevalence ratios (RIIs) compared disease prevalence in the poorest to disease
prevalence in the richest while taking into consideration all other individuals in the regression. Brackets indicate 95% confidence intervals. Model
1 data are adjusted for country of residence and age; model 2 data are adjusted for country of residence, age, marital status, urban/rural area
and education.
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from a variety of settings, which also reported inverse
associations between socioeconomic position and pre-
valence of angina [10,11,56], arthritis [12,13,15,16],
asthma [57,58], and depression [23,24,59-62]. Previ-
ously, European data (including eight higher-income
countries) from the 1990s demonstrated education-
related inequality in 14 of 17 studied NCDs, most not-
ably stroke, diseases of the nervous system and diabetes.
There was a tendency for stronger inequality in adults
aged 25–59 than those aged 60–79 [9]. Goyal et al.
(2010) highlighted differences based on country in-
come group, reporting that education had more of a
protective effect against cardiovascular events in
high-income countries than LMICs, and also among
men [27].
The connection between socioeconomic status and
health is complex, and shaped by diverse circumstantial
factors as well as political, social and economic forces
[63]. For example, people living in poverty mayexperience material deprivation and high stress levels,
which may lead to constrained choices and a higher like-
lihood of engaging in risky health behaviours, increasing
the risk of disease; following disease onset, reduced ac-
cess to care hinders opportunities to prevent complications
[64]. It has been estimated that up to 80% of cases of
cardiovascular disease or type 2 diabetes and 40% of
cancer cases are preventable based on current know-
ledge, however, prevention initiatives may not adequately
reach vulnerable populations where disease risk factors
cluster [65].
Unlike the other four NCDs, we reported higher dia-
betes prevalence among the wealthier and more edu-
cated, especially in LICs. These findings conflict with
trends reported by previous studies conducted in higher-
income countries [25,26]. Epidemiological studies in
lower-income countries are less-forthcoming, however
diabetes was reported to be positively associated with af-
fluence in the Dominican Republic [66], and metabolic
syndrome was positively associated with affluence among
Table 3 Noncommunicable disease prevalence (%) by education level, and education-related inequality among adults of 41 low- and middle-income countries,
World Health Survey 2002-04
Angina Arthritis Asthma Depression Diabetes Co-morbidity





12.0 10.4 13.7 7.9 6.4 9.3 9.2 7.7 10.8 7.1 5.8 8.3 2.7 1.9 3.4 7.7 6.4 9.0
Less than
primary school
10.5 9.3 11.8 7.9 6.7 9.0 6.8 5.9 7.8 5.2 4.2 6.1 3.7 3.0 4.4 7.8 6.7 9.0
Primary school
completed
10.9 9.7 12.1 6.0 5.2 6.8 7.4 6.5 8.2 5.2 4.4 6.0 4.3 3.8 4.9 7.4 6.5 8.2
Secondary/high school
completed
8.5 7.8 9.2 6.1 5.5 6.7 5.7 5.1 6.3 3.2 2.7 3.7 4.1 3.6 4.7 5.2 4.7 5.8
College completed
or above
6.6 5.7 7.4 5.5 4.6 6.4 4.2 3.0 5.3 2.6 1.9 3.3 4.0 3.3 4.7 4.3 3.7 4.9
Slope index
of inequality
Model 1* 4.8 2.0 7.5 1.4 −1.0 3.8 5.3 2.7 7.8 1.6 −0.1 3.3 −1.1 −2.5 0.3 3.1 0.7 5.6





10.2 9.4 11.1 5.2 4.6 5.8 6.4 5.7 7.1 5.5 4.8 6.1 0.8 0.6 1.0 5.5 4.9 6.1
Less than
primary school
10.1 9.1 11.1 4.2 3.6 4.7 5.7 4.8 6.5 4.9 4.2 5.7 1.4 1.0 1.8 5.1 4.4 5.8
Primary school
completed
8.2 7.3 9.1 3.4 2.8 3.9 6.0 5.0 6.9 4.4 3.6 5.1 1.6 1.2 2.1 3.9 3.2 4.5
Secondary/high school
completed
6.4 5.6 7.3 3.5 2.8 4.2 4.6 3.8 5.3 3.8 3.1 4.6 2.6 2.1 3.2 3.0 2.5 3.6
College completed
or above
4.4 3.2 5.7 3.0 2.1 4.0 3.7 2.8 4.7 4.1 3.0 5.1 2.8 2.0 3.5 2.5 1.7 3.3
Slope index
of inequality
Model 1* 7.6 5.2 10.0 2.9 1.1 4.7 4.1 2.3 5.9 1.9 −0.4 4.2 −3.7 −4.9 −2.4 4.8 3.1 6.5





17.9 16.4 19.4 10.7 9.6 11.8 10.2 9.0 11.4 12.0 10.5 13.5 7.7 6.7 8.7 15.2 13.9 16.5
Less than
primary school
17.0 15.2 18.9 8.8 7.9 9.7 9.7 8.8 10.6 7.0 5.9 8.0 5.7 5.1 6.4 11.6 10.7 12.6
Primary school
completed
16.2 14.8 17.5 11.8 10.7 12.9 7.7 6.7 8.6 7.6 6.2 8.9 6.3 5.6 7.0 11.9 10.7 13.1
Secondary/high school
completed
13.3 12.5 14.2 8.8 8.1 9.5 6.2 5.7 6.8 5.7 5.0 6.4 5.1 4.5 5.7 8.8 8.1 9.5
College completed
or above
9.5 8.5 10.4 8.8 7.9 9.6 3.9 3.3 4.6 5.1 4.3 6.0 2.9 2.4 3.5 5.6 4.9 6.3
Slope index
of inequality
Model 1* 5.6 1.9 9.3 0.0 −2.6 2.6 4.7 1.1 8.4 3.0 0.5 5.5 0.3 −2.0 2.6 3.8 0.5 7.2




















Table 3 Noncommunicable disease prevalence (%) by education level, and education-related inequality among adults of 41 low- and middle-income countries,





14.7 13.9 15.5 6.1 5.7 6.6 7.1 6.5 7.7 8.4 7.8 9.0 1.1 0.9 1.3 7.7 7.1 8.2
Less than
primary school
15.1 13.9 16.3 6.4 5.4 7.5 5.7 5.0 6.4 7.4 6.5 8.3 2.6 2.0 3.3 7.1 6.2 8.0
Primary school
completed
11.6 10.2 13.0 5.4 4.5 6.3 6.2 5.2 7.2 5.9 5.0 6.8 2.2 1.7 2.7 5.4 4.5 6.3
Secondary/high school
completed
10.6 9.4 11.9 5.9 5.0 6.8 5.5 4.7 6.4 6.2 5.1 7.3 3.2 2.5 4.0 6.6 5.6 7.7
College completed
or above
9.0 7.5 10.6 3.9 2.9 4.9 3.1 1.9 4.3 3.4 2.2 4.5 3.5 2.6 4.4 3.9 2.9 4.9
Slope index
of inequality
Model 1* 7.8 4.6 11.0 2.6 0.2 5.0 1.9 −0.1 3.8 6.6 4.3 8.9 −4.6 −6.7 −2.5 5.3 2.9 7.8
Model 2** 3.8 0.2 7.5 1.2 −1.7 4.1 1.3 −0.8 3.4 4.5 1.7 7.3 −1.8 −3.4 −0.1 3.9 1.0 6.8
* Model 1 is adjusted for country of residence and age.




















Figure 2 Education-related relative inequality in non-communicable diseases among adults of 41 low- and middle-income countries.
The relative index of inequality shows education-related inequality in prevalence of angina, arthritis, asthma, depression, diabetes and
comorbidity, among men and women aged 18 or higher, living in 41 low- and middle-income countries that participated in the 2002–04 World
Health Survey. Individuals were cumulatively ranked by descending education level, and prevalence ratios (RIIs) compared disease prevalence in
the least educated group to disease prevalence in the most educated group while taking into consideration all other groups in the regression.
Brackets indicate 95% confidence intervals. Model 1 data are adjusted for country of residence and age; model 2 data are adjusted for country of
residence, age, marital status, urban/rural area and wealth.
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development may realize different stages of disease epi-
demiological transitions [67]. Noting methodological dif-
ferences in determining diabetes prevalence, it is also
possible that our findings may be subjected to bias stem-
ming from a methodology issue whereby cases with a
lower wealth or education were more likely to be under-
diagnosed and therefore prevalence rates were underesti-
mated. Populations in less-developed nations may have
limited access to medical professionals [6], which could
result in under-diagnosis of diabetes, particularly among
populations of lower socio-economic status; for example,
better educated individuals may be more aware of dia-
betes as a health condition. Alternatively, this finding
may reflect a complex relationship between wealth, over-
weight, obesity, other risk factors (such as physical in-
activity), and diabetes [68]. Ideally, future surveys may
integrate objective indicators of disease, such as HbA1C
diagnostic testing for diabetes [69].
Comorbidity significantly lowers quality of life, affect-
ing physical, social and psychological well-being [70].
Our findings showed that comorbidity was more preva-
lent among the poor and less educated, in all sex-
income groups. We reported overall comorbidity ratesof up to 10%, with even greater prevalence in some
poorer wealth quintiles and least educated subpopula-
tions. In a multinational study of high-income countries
30.2% of adults over 18 reported more than one chronic
condition, although the study included seven diseases
whereas ours included five [71]. Consistent with the
present study, previous research has reported inverse
associations between comorbidity and markers of socio-
economic status [30].
Like other studies, NCD prevalence tended to be
higher in women than men [30], and the greatest burden
was reported for a cardiovascular-related condition [3].
Overall, study NCDs tended to be more prevalent in the
MIC group, with the exception of depression. That de-
pression rates were higher in LICs than MICs was not
expected. Previously, depression prevalence was reported
to be lower in a less-developed setting, although cultural
willingness to report depressive symptoms may bias out-
comes [72]. According to epidemiological transition
models, LICs may be expected to carry a lower-- albeit
increasing-- burden of NCDs than higher-income coun-
try groups, as risk factors for infectious diseases are pro-
gressively replaced by risk factors for NCDs [73].
Projections for 2005–2030 forecasted a 10% increase in
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to 71%) [74]. Monitoring trends in NCD prevalence in
LMIC groups will help to characterize the nature of the
modern epidemiological transition, and identify popula-
tions that are most at risk for NCDs.
Strengths, limitations and implications
Data for five NCDs were collected systematically in a
large sample of LMICs that participated in the WHS,
allowing for comparisons of standardized data across
pooled data sets. Consistent diagnostic criteria in WHS
data facilitated broad-scale analyses and comparisons
across several countries, minimizing limitations asso-
ciated with variable measurement tools and disease clas-
sifications. However, the use of pooled data from
geographically- and culturally-diverse settings inevitably
masks problems of comparability between countries
[54]. Nine studies were excluded from analysis due to in-
sufficient data or high item non-response rates. There is
no reason to believe that the excluded countries would
have changed the main findings on socioeconomic in-
equality in LMICs. The non-response was not selective,
including countries of both low and middle income
groups. We included a country variable in our multivari-
ate analysis in order to control for any potential con-
founding effect of the individual countries. We did not
aim to explore the interaction effects of our study’s inde-
pendent variables with each of the countries.
Wealth and education levels were determined nation-
ally, and pooled across LICs and MICs. We acknowledge
that patterns of wealth distribution vary between coun-
tries, however, quintile classification provided a widely
accepted method to compare respondents based on rela-
tive wealth position within their country. Levels of edu-
cation were standardized to be comparable across
countries.
The use of symptom-based diagnoses for angina, arth-
ritis, asthma and depression was a strength, as other
methods that rely on medical charts or self-reported
diagnoses may introduce biases related to health system
access. Self-reported data could reflect systematic over-
or under-reporting, which may vary by socioeconomic
status [75]. A tendency for under-reporting of symptoms
by people with low levels of education [76] raises the
possibility that our data may underestimate prevalence
in low education classes, and show weaker-than-actual
inverse associations. As a result, our data may underesti-
mate true NCD rates in socioeconomic disadvantaged
populations.
It is possible that a selection bias may have occurred
in the sampling process, especially in countries with
lower response rate, although we are not aware of evi-
dence to suggest that this had occurred. The main rea-
sons for household non-response included inability tolocate the selected household, or household refusal to
participate even before a roster could be obtained.
Conclusions
Action taken in the next 20 years will be critical in de-
termining the outcome of the mounting NCD epidemic
[77]. One of the major reasons for the relative failure of
NCD advocacy is a lack of emphasis on social justice
and inequality [78]. Delineating the impact of NCDs on
poor and rich populations-- both between country-
income groupings and within countries --is an import-
ant precursor to NCD prevention and management
efforts.
The focus of this study was to assess within-country
socioeconomic distribution of five NCDs and comorbid-
ity in LMICs. We reported disparities between subpopu-
lations of different wealth- and education-levels, which
varied according to the type of NCD. With the exception
of diabetes, four NCDs and their comorbidity showed
some evidence for unequal distribution in populations,
to the detriment of those with lower wealth or education
levels. Angina, asthma and comorbidity prevalence dem-
onstrated the strongest inverse associations with wealth
and education; arthritis and depression also reported in-
verse wealth and education associations in most cases.
In LICs, diabetes prevalence was significantly positively
associated with wealth and education.
Overall, our mixed findings substantiate the need for
disaggregated research to delineate the impact of indi-
vidual NCDs on various socioeconomic groups. High
quality epidemiological evidence is a cornerstone of ef-
fective policy development, deployment and monitoring.
The present study has shown that NCDs are not neces-
sarily diseases of the wealthy, demonstrating unequal
distribution across socioeconomic groups. Further inves-
tigation of the risk factors and root causes of socioeco-
nomic inequality are warranted to formulate sustainable
and effective approaches to prevent and manage NCDs
among the poor and low educated.
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